Type
Business expansion
Country
Ireland
Region
Border, Midland and Western; West; West
Location of affected unit(s)
Limerick
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

400 jobs
Number of planned job creations
Job creation
Announcement Date
27 August 2020
Employment effect (start)
27 August 2020
Foreseen end date

Description

Biopharma pharmaceutical company Regeneron is to create 400 new jobs at its plant in Limerick.

The new roles are in commercial manufacturing, process sciences, quality assurance/control, supply chain and various support functions for scientists, chemists and technicians.

Regeneron already employs around 1,000 people in Ireland. The company, operating in Ireland since 2015, has invested over €850m to make its manufacturing plant, the former Dell company site, the largest bulk biologics facility in Ireland.

The company is also involved in developing treatment for COVID-19.


Sources

Citation

Eurofound (2020), Regeneron, Business expansion in Ireland, factsheet number 101554, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/101554.